{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T01:00:04Z","timestamp":1781830804308,"version":"3.54.5"},"reference-count":28,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.vaccine.2015.03.104","type":"journal-article","created":{"date-parts":[[2015,4,16]],"date-time":"2015-04-16T01:51:45Z","timestamp":1429149105000},"page":"2594-2601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Immunogenicity and reactogenicity of a decennial booster dose of a combined reduced-antigen-content diphtheria\u2013tetanus\u2013acellular pertussis and inactivated poliovirus booster vaccine (dTpa\u2013IPV) in healthy adults"],"prefix":"10.1016","volume":"33","author":[{"given":"Martina","family":"Kovac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niraj","family":"Rathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherine","family":"Kuriyakose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Hardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tino F.","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.03.104_bib0145","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/S0140-6736(06)68848-X","article-title":"Recent developments in pertussis","volume":"367","author":"Crowcroft","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.03.104_bib0150","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/01.revmedmi.0000175933.85861.4e","article-title":"Pertussis: a concise historical review including diagnosis, incidence, clinical manifestations and the role of treatment and vaccination in management","volume":"16","author":"Versteegh","year":"2005","journal-title":"Rev Med Microbiol"},{"key":"10.1016\/j.vaccine.2015.03.104_bib0155","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.prrv.2008.05.010","article-title":"Pertussis: review of epidemiology, diagnosis, management and prevention","volume":"9","author":"Wood","year":"2008","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.vaccine.2015.03.104_bib0160","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.vaccine.2010.10.025","article-title":"A decennial booster dose of reduced antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix) is immunogenic and well tolerated in adults","volume":"29","author":"Booy","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.104_bib0165","doi-asserted-by":"crossref","first-page":"e5919","DOI":"10.1136\/bmj.e5919","article-title":"Teenagers and newborn babies in England and Wales may get pertussis jab as cases continue to rise","volume":"345","author":"Gulland","year":"2012","journal-title":"Br Med J"},{"key":"10.1016\/j.vaccine.2015.03.104_bib0170","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1097\/01.inf.0000160914.59160.41","article-title":"Duration of immunity against pertussis after natural infection or vaccination","volume":"24","author":"Wendelboe","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2015.03.104_bib0175","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1056\/NEJMp1209051","article-title":"Epidemic pertussis in 2012\u2014the resurgence of a vaccine-preventable disease","volume":"367","author":"Cherry","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.03.104_bib0180","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.vaccine.2011.11.035","article-title":"Immune responses in adults to revaccination with a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine 10 years after a previous dose","volume":"30","author":"Halperin","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.104_bib0185","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.vaccine.2010.12.010","article-title":"The Global Pertussis Initiative: report from a round table meeting to discuss the epidemiology and detection of pertussis, Paris, France, 11\u201312 January 2010","volume":"29","author":"Guiso","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.104_bib0190","doi-asserted-by":"crossref","first-page":"5903","DOI":"10.1016\/j.vaccine.2013.09.020","article-title":"Can vaccine legacy explain the British pertussis resurgence","volume":"31","author":"Riolo","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.104_bib0195","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1542\/peds.112.2.405","article-title":"The science and fiction of the resurgence of pertussis","volume":"112","author":"Cherry","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2015.03.104_bib0200","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s40259-012-0009-y","article-title":"Reduced-antigen, combined diphtheria, tetanus, and acellular pertussis vaccine, adsorbed (Boostrix(\u00ae)): a guide to its use as a single-dose booster immunization against pertussis","volume":"27","author":"Scott","year":"2013","journal-title":"BioDrugs"},{"key":"10.1016\/j.vaccine.2015.03.104_bib0205","doi-asserted-by":"crossref","first-page":"e01074","DOI":"10.1128\/mBio.01074-14","article-title":"Global population structure and evolution of Bordetella pertussis and their relationship with vaccination","volume":"5","author":"Bart","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.vaccine.2015.03.104_bib0210","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.meegid.2009.10.007","article-title":"Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen","volume":"10","author":"Mooi","year":"2010","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.vaccine.2015.03.104_bib0215","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1542\/peds.2004-2648","article-title":"The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection","volume":"115","author":"Cherry","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2015.03.104_bib0220","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1086\/655825","article-title":"Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adults","volume":"51","author":"Mertsola","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2015.03.104_bib0225","first-page":"131","article-title":"Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women\u2014Advisory Committee on Immunization Practices (ACIP), 2012","volume":"62","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2015.03.104_bib0230","series-title":"Vaccination against pertussis (Whooping cough) for pregnant women\u20142014","author":"Public Health England","year":"2014"},{"key":"10.1016\/j.vaccine.2015.03.104_bib0235","series-title":"The Australian immunisation handbook. Pertussis","author":"Australian Government Department of Health","year":"2013"},{"key":"10.1016\/j.vaccine.2015.03.104_bib0240","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1473-3099(11)70007-X","article-title":"Rationale for pertussis booster vaccination throughout life in Europe","volume":"11","author":"Zepp","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2015.03.104_bib0245","doi-asserted-by":"crossref","first-page":"554","DOI":"10.4161\/hv.6.7.11760","article-title":"Repeated administration of a reduced-antigen-content diphtheria\u2013tetanus\u2013acellular pertussis and poliomyelitis vaccine (dTpa\u2013IPV; Boostrix IPV)","volume":"6","author":"Knuf","year":"2010","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2015.03.104_bib0250","series-title":"Travellers health","author":"Centers for Disease Control and Prevention","year":"2014"},{"key":"10.1016\/j.vaccine.2015.03.104_bib0255","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00431-005-1650-y","article-title":"Reduced-antigen-content-diphtheria\u2013tetanus\u2013acellular\u2013pertussis and inactivated polio vaccine as a booster for adolescents 10 to 14 years of age","volume":"164","author":"Vergara","year":"2005","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.vaccine.2015.03.104_bib0260","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1016\/j.vaccine.2005.02.013","article-title":"Combined reduced-antigen-content diphtheria\u2013tetanus\u2013acellular pertussis and polio vaccine (dTpa\u2013IPV) for booster vaccination of adults","volume":"23","author":"Grimprel","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.104_bib0265","first-page":"656","article-title":"Boostrix (GlaxoSmithKline)","volume":"8","author":"Jones","year":"2005","journal-title":"Investig Drugs J"},{"key":"10.1016\/j.vaccine.2015.03.104_bib0270","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jpeds.2006.06.016","article-title":"Safety of reduced-antigen-content tetanus\u2013diphtheria\u2013acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine","volume":"149","author":"Zepp","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2015.03.104_bib0275","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1097\/01.inf.0000160917.29723.03","article-title":"Potential strategies to reduce the burden of pertussis","volume":"24","author":"Forsyth","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2015.03.104_bib0280","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/01.mej.0000184993.51799.ad","article-title":"Combined diphtheria\u2013tetanus\u2013pertussis vaccine for tetanus-prone wound management in adults","volume":"13","author":"Hoel","year":"2006","journal-title":"Eur J Emerg Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15004430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15004430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T13:25:41Z","timestamp":1537709141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15004430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":28,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0264410X15004430"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.03.104","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and reactogenicity of a decennial booster dose of a combined reduced-antigen-content diphtheria\u2013tetanus\u2013acellular pertussis and inactivated poliovirus booster vaccine (dTpa\u2013IPV) in healthy adults","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.03.104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}